International Journal of Diabetes and Endocrinology

Submit a Manuscript

Publishing with us to make your research visible to the widest possible audience.

Propose a Special Issue

Building a community of authors and readers to discuss the latest research and develop new ideas.

Efficacy of Comprehensive Diabetes Care (CDC) Therapy in Patients of Type II Diabetes Mellitus: Relapse of the Disease

Diabetes mellitus (DM) prevalence is rising worldwide at an alarming rate, with India leading the pack with the highest percentage of people with diabetes. The typical diabetic treatment solutions that are currently accessible have some drawbacks, so some alternate treatments are needed. The traditional medicine of India, Ayurveda, contains many treatments for diabetes and its consequences. This study was conducted to study the CDC's effectiveness in treating T2DM relapse in patients with restored glycemia. A total of 25 patients with restored Euglycemia of either sex and aged between 30-70 years suffering from T2DM and completed 1-year follow-up were included in the study. The Comprehensive Diabetes Care (CDC) therapy, a three-step detoxification procedure- Snehana, i.e. oleation, Swedana, i.e. passive heat therapy, and Basti, i.e. per rectal drug administration and food therapy was administrated to the patients. The data of their clinical parameters were evaluated. The weight, BMI, ABG, SBP, and DBP values were seen to be reduced after 90 days of the treatment but slightly increased after 1-year post-treatment of CDC therapy. Also, HbA1c was found to be reduced after 90 days, and after one year of follow-up, a slight increase in HbA1c value was seen. The overall change was -21.11% (p-value=0.00). The reduction in allopathic medicines was observed after 90 days and also after 1 year of follow-up. Even though 8% of the patients experienced a Type 2 DM relapse, the other 92% were still non-diabetic after one year.

Comprehensive Diabetes Care, Type II Diabetes Mellitus, Restored Euglycemia

APA Style

Nilesh Kulthe, Karishma Khair, Rahul Mandole, Pravin Ghadigaonkar. (2023). Efficacy of Comprehensive Diabetes Care (CDC) Therapy in Patients of Type II Diabetes Mellitus: Relapse of the Disease. International Journal of Diabetes and Endocrinology, 8(4), 45-49. https://doi.org/10.11648/j.ijde.20230804.11

ACS Style

Nilesh Kulthe; Karishma Khair; Rahul Mandole; Pravin Ghadigaonkar. Efficacy of Comprehensive Diabetes Care (CDC) Therapy in Patients of Type II Diabetes Mellitus: Relapse of the Disease. Int. J. Diabetes Endocrinol. 2023, 8(4), 45-49. doi: 10.11648/j.ijde.20230804.11

AMA Style

Nilesh Kulthe, Karishma Khair, Rahul Mandole, Pravin Ghadigaonkar. Efficacy of Comprehensive Diabetes Care (CDC) Therapy in Patients of Type II Diabetes Mellitus: Relapse of the Disease. Int J Diabetes Endocrinol. 2023;8(4):45-49. doi: 10.11648/j.ijde.20230804.11

Copyright © 2023 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1. A. Aguilar-Salinas, H. Bourges-Rodriguez, E. Polo-Oteyza, et al. Prevention of diabetes in Mexico: summary of evidence on preventive interventions presented at the 2014 Nestle Nutrition Conference Nutr. Rev., 75 (suppl 1) (2017), pp. 1-3.
2. V. Perez Siwik, R. M. Kutob, C. Ritenbaugh, M. Aickin, et al. Families United/Familias Unidas: development and implementation of a family-based group office visit model for the primary prevention of type 2 diabetes Diabetes Educ., 38 (6) (2012), pp. 811-821.
3. J. Lindström, A. Louheranta, M. Mannelin, et al., Finnish Diabetes Prevention Study Group. The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity Diabetes Care, 26 (12) (2003), pp. 3230-3236.
4. Rebeca Reyes-Garcia, Oscar Moreno-Perez, Cristina Tejera-Perez, et al. A comprehensive approach to type 2 diabetes mellitus – A recommendation document. Endocrinología, Diabetes y Nutrición (English ed.) Volume 66, Issue 7, August–September 2019, Pages 443-458.
5. Mehta S, Kashyap A, Das S. Diabetes Mellitus in India: The Modern Scourge. Med J Armed Forces India. 2009; 65 (1): 50- 4.
6. Stein S, Lamos E, Davis S. A review of the efficacy and safety of oral antidiabetic drugs. Expert Opin Drug Saf. 2013; 12 (2): 153-75.
7. Payne C (2001) Complementary and integrative medicine: Emerging therapies for diabetes, Part I. Diabetes Spectrum 14: 129-131.
8. Ashok Kumar Panda. Comprehensive Ayurvedic Care in Type-2 Diabetes. J Homeop Ayurv Med 2014, 3: 1.
9. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Retrieved from http://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdf [Last accessed on Dec 21st 2017].
10. Uebaba K, Xu F, Ogawa H, et al. Psychoneuroimmunologic effects of ayurvedic oil dripping treatment. J Altern Complement Med. 2008; 14: 1189–1198.
11. Giri S, Patnaik S, Kumar K, et al. The potential of Ayurvedic panchakarma in preventing and managing lifestyle disorders with special reference to Madhumeha, J of Ayurveda and Hol Med (JAHM). 2015; 3 (5): 82-91.
12. Verma M, Paneri S, Badi P, et al. Effect of increasing duration of diabetes mellitus type 2 on glycated haemoglobin and insulin sensitivity. Indian Journal of Clinical Biochemistry, 2006, 21 (1): 142-146.
13. “Clinical importance of Glycosylated haemoglobin (HbA1c) in diabetes mellitus patients”. Retrieved from https://www.researchgate.net/publication/26575867_Clinical_Importance_Of_Glycosylated_Hemoglobin_HbA1c_In_Diabetes_Mellitus_Patients. [Last accessed on March 11th 2018].
14. Chaudhury A, Duvoor C, Reddy V, et al. Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management. Front. Endocrinol. 2017; 8 (6): 1-12.